5ml Semaglutide Pens: What the Volume Means for Your Wegovy Treatment

Step 1: Understanding what 5ml actually describes

The 5ml figure printed on a Wegovy pen is the total solution volume inside the device. It is not the dose. Every strength in the Wegovy range (from the 0.25mg starter pen right through to the 2.4mg maintenance pen) uses the same 5ml cartridge format. What changes between pens is the concentration of semaglutide dissolved in that solution, which is why the pre-set injection volume you receive each week looks similar across strengths while the amount of active medicine delivered is quite different.

This catches people out when they read product descriptions online. A listing for "5ml semaglutide" is almost certainly describing a Wegovy pen by its device volume, and if you have come across references to 15ml semaglutide while browsing product options, that describes a different device format entirely rather than a stronger or alternative version of Wegovy. The Wegovy Summary of Product Characteristics sets out exactly how much semaglutide each pen delivers per injection, that document is the authoritative reference for this detail, and your prescriber will use it alongside your clinical picture when deciding which strength is right for you.

A question our prescribers hear most weeks: "Can I just order the 5ml pen with the most semaglutide in it?" The honest answer is no, and not only because it requires a prescription. Starting at a higher strength than your body is ready for makes the well-known gastrointestinal side effects considerably worse, and there is no shortcut that changes that biology.

Step 2: Walking through the licensed UK titration sequence

Wegovy treatment in the UK follows a gradual step-up schedule that the prescriber oversees. You begin at 0.25mg once weekly, a dose designed to let your system adjust, not to produce immediate weight loss. After roughly four weeks, the prescriber moves you to 0.5mg, then to 1mg, then 1.7mg, and finally to the 2.4mg maintenance dose, each step separated by about a month. The NHS patient information for semaglutide, available on the NHS medicines page for semaglutide, walks through this sequence clearly and is worth reading before you start.

In April 2026, the MHRA approved a dedicated single-dose 7.2mg pen for adults with a BMI of 30 or above, representing the highest available maintenance dose for Wegovy. Trials at this strength reported an average weight reduction of around 20.7% over 72 weeks, which narrows the gap with tirzepatide results considerably. Availability of specific pen formats is confirmed at consultation, the dose you'll be prescribed depends on where you are in your treatment journey and what your prescriber judges appropriate. For more on how Wegovy fits into weight management overall, the treatment overview covers the broader picture.

Missing a dose, or deciding to slow your own titration, should always involve a conversation with your prescriber rather than a self-managed adjustment. The Patient Information Leaflet inside your pen box is the place to look for what to do if a dose is late.

Step 3: Eligibility, common side effects, and getting the process right

Wegovy is licensed for adults with a BMI of 30 or above, or 27 and above if at least one weight-related condition is present, for example, high blood pressure, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. Meeting the numbers is the start of the eligibility picture, not the whole of it: a prescriber also looks at your medical history, any medicines you already take, and whether there are clinical reasons Wegovy would not be appropriate for you. It is not recommended during pregnancy, while breastfeeding, or if you are trying to conceive, and it is not licensed for under-18s.

The side effects most people notice are gastrointestinal: nausea, constipation, loose stools, indigestion and burping are common, particularly during the early weeks of treatment or after a dose increase. They typically ease as your body adjusts. Seek urgent medical attention if you develop severe, persistent stomach pain that spreads towards your back, this can be a sign of pancreatitis, which the MHRA flagged in a Drug Safety Update for GLP-1 medicines in January 2026. Suspected side effects can be reported at the MHRA's Yellow Card scheme.

If cost is a factor in your thinking, our guide to Wegovy pricing in the UK sets out what a legitimate private prescription typically costs and what those prices do and don't include. It is worth reading before comparing providers.

Step 4: Private access through a regulated pharmacy

Wegovy is a prescription-only medicine, so the legal route to it in the UK is a clinical assessment with a prescriber followed by a prescription, every time, including for repeat supplies. On the NHS, access is through specialist weight management services under NICE guidance, and waiting lists can be long. A GPhC-registered online pharmacy is the alternative for people who want to start sooner or who do not meet the current NHS criteria.

At nume, every consultation is personally reviewed the same day by a GPhC-registered Independent Prescriber. That means a real clinician reads your answers, not an automated system. If treatment is clinically appropriate, your pen is dispatched the same day for free next-working-day delivery with DPD. You can verify our pharmacy on the GPhC register, registration number 9012878. Worth checking.

If you are already on Wegovy and looking at dose-specific information, the pages covering 1mg semaglutide and 2mg semaglutide address the questions that come up at those particular stages. For a broader look at weight-loss treatment options, including how Wegovy compares with other licensed medicines, the overview is a useful starting point before speaking to a prescriber.